Drawing based on the label description. No photo yet.
“25 mg white to off-white, round, biconvex film coated tablets debossed with '5L' on one side and plain on other side”
5L pill
Pill with imprint 5L is white, round, 12 mm and has been identified as Rilpivirine 25 mg. It is used for HIV. It is supplied by Laurus Labs Limited.
Rilpivirine 25 mg
- Imprint
- 5L
- Strength
- 25 mg
- Used for
- HIV
- Color
- White
- Shape
- Round
- Size
- 12 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Laurus Labs Limited
- Drug class
- HIV medicine
- NDC
- 42385-999, 42385-999-30, 42385-999-31
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Rilpivirine used for?
Rilpivirine is used for HIV.
- Medicine type
- HIV medicine
Official uses from the US prescribing label
Treatment of HIV-1 in Treatment-Naïve Patients
EDURANT and EDURANT PED, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-naïve patients 2 years of age and older and weighing at least 14 kg with plasma HIV-1 RNA less than or equal to 100,000 copies/mL at the start of therapy.
Limitations of Use
- More EDURANT treated subjects with HIV-1 RNA greater than 100,000 copies/mL at the start of therapy experienced virologic failure (HIV-1 RNA ≥50 copies/mL) compared to EDURANT treated subjects with HIV-1 RNA less than or equal to 100,000 copies/mL.
Treatment of HIV-1 in Combination with Cabotegravir
EDURANT is indicated in combination with VOCABRIA (cabotegravir) for short-term treatment of HIV-1 infection in adults and adolescents 12 years and older and weighing at least 35 kg who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine, for use as:
- oral lead-in to assess the tolerability of rilpivirine prior to administration of rilpivirine extended-release injectable suspension, a component of CABENUVA (cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension).
- oral therapy for patients who will miss planned injection dosing with CABENUVA (cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension).
From the FDA-approved label on DailyMed (published Sep 01, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows 5L and the other side is plain.
- It is white, round, 12 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Rilpivirine Hydrochloride
Inactive: Croscarmellose Sodium, Lactose Monohydrate, Magnesium Stearate, Polysorbate 20, Povidone K30, Silicified Microcrystalline Cellulose (125 .micro.m, High-Density), Hypromellose 2910 (6 Mpa.s), Polyethylene Glycol 8000, Titanium Dioxide
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AA 16
Desipramine 150 mg
White, round, 11 mm
Used for depression and ADHD
-
C 17
Aminocaproic Acid 500 mg
White, round, 13 mm
Used for hemorrhage
-
CN500
Chloroquine Phosphate 500 mg
White, round, 13 mm
Used for rheumatoid arthritis and amoeba infection
-
A65
Everolimus 5 mg
White, round, 12 mm
Used for seizures
-
AA 99
Nadolol 80 mg
White, round, 11 mm
Used for high blood pressure and heart failure
-
IP 271
Sulfamethoxazole and Trimethoprim 400 mg / 80 mg
White, round, 13 mm
Used for urinary tract infections (UTIs)